Canakinumab Subcutaneous and Fulphila Injection
Determining the interaction of Canakinumab Subcutaneous and Fulphila Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: pegfilgrastim
Brand name: Fulphila, Neulasta, Neulasta Onpro Kit, Udenyca, Neulasta Delivery Kit
Synonyms: Fulphila
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Fulphila Subcutaneous
- Canakinumab Subcutaneous-Fulvestrant
- Canakinumab Subcutaneous-Fulvestrant Injection
- Canakinumab Subcutaneous-Fulvestrant Intramuscular
- Canakinumab Subcutaneous-Fulvicin P/G
- Canakinumab Subcutaneous-Fulvicin-U/F
- Fulphila Injection-Canasa
- Fulphila Injection-Canasa Pac rectal
- Fulphila Injection-Canasa rectal
- Fulphila Injection-Cancidas
- Fulphila Injection-Candesartan
- Fulphila Injection-Candesartan and Hydrochlorothiazide